Dr Jacobs comments on a study of the effects of the common pollutants PAHs on cognitive ability and behavioral problems in urban school-age children.

When the Antibiotic Resistance National Action Plan was announced, our readers had many concerns and questions. We asked CDC Director Tom Frieden for answers.

Occult magnesium deficiency may be responsible for innumerable ailments, but plasma and serum levels are unreliable measures. Dr Lundberg offers his advice for addressing this important problem.

A review of 30 RCTs reveals which nonpharmacologic interventions are and are not effective in reducing agitation.

The risk goes in both directions: Your patients traveling to or from the tropics could be at risk for -- or bringing back -- the chikungunya virus.

By fall, there may be two new drugs in the lipid-lowering toolbox. Seth Bilazarian quizzes Marc Sabatine about what this means for the lipid landscape and the use of a genetic risk score.

Dr Silvio Inzucchi describes the ongoing quest to determine whether any diabetes medications might help lower cardiovascular risks.

A growing body of evidence shows that neuraminidase inhibitor antiviral drugs are effective against the flu, reducing complications and saving lives among hospitalized patients.

Dr Jo-Ann Manson describes the high-risk groups that should be screened for hypo- or hyperthyroidism.

Euan Ashley, self-described geek-turned-cardiologist, discusses how big data can help you practice smarter medicine.